219 related articles for article (PubMed ID: 34053984)
21. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA
Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033
[TBL] [Abstract][Full Text] [Related]
22. Uncommon somatic mutations in metastatic NUT midline carcinoma.
Cavalieri S; Stathis A; Fabbri A; Sonzogni A; Perrone F; Tamborini E; Pelosi G; de Braud F; Platania M
Tumori; 2017 Nov; 103(Suppl. 1):e5-e8. PubMed ID: 28967088
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.
Fang W; French CA; Cameron MJ; Han Y; Liu H
Int J Surg Pathol; 2013 Apr; 21(2):102-10. PubMed ID: 22777717
[TBL] [Abstract][Full Text] [Related]
24. NUT midline carcinoma of the parotid gland with mesenchymal differentiation.
den Bakker MA; Beverloo BH; van den Heuvel-Eibrink MM; Meeuwis CA; Tan LM; Johnson LA; French CA; van Leenders GJ
Am J Surg Pathol; 2009 Aug; 33(8):1253-8. PubMed ID: 19561446
[TBL] [Abstract][Full Text] [Related]
25. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
[No Abstract] [Full Text] [Related]
26. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
27. Cytologic findings of NUT midline carcinoma in the hilum of the lung.
Policarpio-Nicolas ML; de Leon EM; Jagirdar J
Diagn Cytopathol; 2015 Sep; 43(9):739-42. PubMed ID: 26138851
[TBL] [Abstract][Full Text] [Related]
28. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.
French CA; Rahman S; Walsh EM; Kühnle S; Grayson AR; Lemieux ME; Grunfeld N; Rubin BP; Antonescu CR; Zhang S; Venkatramani R; Dal Cin P; Howley PM
Cancer Discov; 2014 Aug; 4(8):928-41. PubMed ID: 24875858
[TBL] [Abstract][Full Text] [Related]
29. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
30. A case of endobronchial NUT midline carcinoma with intraluminal growth.
Watanabe S; Hirano S; Mine S; Yoshida A; Motoi T; Ishii S; Naka G; Takeda Y; Igari T; Sugiyama H; Kobayashi N
Anticancer Res; 2015 Mar; 35(3):1607-12. PubMed ID: 25750317
[TBL] [Abstract][Full Text] [Related]
31. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
32. Sinonasal NUT midline carcinoma: A new histological entity.
Vakani PN; Maheshwari J; Maheshwari M; Shah B
Indian J Pathol Microbiol; 2020; 63(1):103-105. PubMed ID: 32031134
[TBL] [Abstract][Full Text] [Related]
33. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
34. NUT carcinoma in a nutshell: A diagnosis to be considered more frequently.
Albrecht T; Harms A; Roessler S; Goeppert B
Pathol Res Pract; 2019 Jun; 215(6):152347. PubMed ID: 30782401
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.
Haack H; Johnson LA; Fry CJ; Crosby K; Polakiewicz RD; Stelow EB; Hong SM; Schwartz BE; Cameron MJ; Rubin MA; Chang MC; Aster JC; French CA
Am J Surg Pathol; 2009 Jul; 33(7):984-91. PubMed ID: 19363441
[TBL] [Abstract][Full Text] [Related]
36. BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.
Nelson BA; Lee EY; French CA; Bauer DE; Vargas SO
J Thorac Imaging; 2010 Aug; 25(3):W93-6. PubMed ID: 20395873
[TBL] [Abstract][Full Text] [Related]
37. NUT midline carcinoma: case report and review of the literature.
Hsieh MS; French CA; Liang CW; Hsiao CH
Int J Surg Pathol; 2011 Dec; 19(6):808-12. PubMed ID: 20034986
[TBL] [Abstract][Full Text] [Related]
38. NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.
Tanaka M; Kato K; Gomi K; Yoshida M; Niwa T; Aida N; Kigasawa H; Ohama Y; Tanaka Y
Am J Surg Pathol; 2012 Mar; 36(3):381-8. PubMed ID: 22301500
[TBL] [Abstract][Full Text] [Related]
39. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M
BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]